|
---|
Category:Meeting Agenda
MONTHYEARPMNS20230480, Meeting with Shine Technologies LLC to Discuss Change in Seismic Approach for the Installation of Process Equipment2023-04-27027 April 2023 Meeting with Shine Technologies LLC to Discuss Change in Seismic Approach for the Installation of Process Equipment ML22279B0542022-10-21021 October 2022 Agenda - Shine - Sc - October 21, 2022 PMNS20220959, Public Meeting with Shine Medical Technologies, LLC - Discussion of Phased Approach to Construction and Operation2022-09-12012 September 2022 Public Meeting with Shine Medical Technologies, LLC - Discussion of Phased Approach to Construction and Operation PMNS20220659, Public Meeting to Discuss the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility2022-07-0606 July 2022 Public Meeting to Discuss the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility PMNS20220448, Public Meeting with Shine Medical Technologies, LLC - Discussion of Cybersecurity Program2022-06-29029 June 2022 Public Meeting with Shine Medical Technologies, LLC - Discussion of Cybersecurity Program PMNS20220313, Public Meeting with Shine Medical Technologies, LLC - Discussion of Cyber Security Program2022-05-0202 May 2022 Public Meeting with Shine Medical Technologies, LLC - Discussion of Cyber Security Program PMNS20211565, Public Meeting with Shine Medical Technologies, LLC - Discussion of Phased Approach to Construction and Operation2021-12-13013 December 2021 Public Meeting with Shine Medical Technologies, LLC - Discussion of Phased Approach to Construction and Operation PMNS20211212, Shine Medical Technologies, LLC - Discussion on Engineered Safety Features and Auxiliary Systems2021-09-17017 September 2021 Shine Medical Technologies, LLC - Discussion on Engineered Safety Features and Auxiliary Systems PMNS20211033, Shine Medical Technologies, LLC - Radiation Damage Topics Related to Operating License Application2021-08-17017 August 2021 Shine Medical Technologies, LLC - Radiation Damage Topics Related to Operating License Application PMNS20210629, Shine Medical Technologies, LLC - Discussion on Structural Analysis Associated with Operating License Application2021-05-10010 May 2021 Shine Medical Technologies, LLC - Discussion on Structural Analysis Associated with Operating License Application PMNS20210334, Shine Medical Technologies, LLC - Discussion of Staggered Approach to Construction, Operation, and Licensing2021-04-0606 April 2021 Shine Medical Technologies, LLC - Discussion of Staggered Approach to Construction, Operation, and Licensing PMNS20210231, Shine Medical Technologies, LLC - Follow-up Discussion on Electrical Power Systems RAI Responses2021-03-15015 March 2021 Shine Medical Technologies, LLC - Follow-up Discussion on Electrical Power Systems RAI Responses PMNS20210229, Shine Medical Technologies, LLC - Proposed Amendment to Construction Permit for Possession of Materials2021-02-25025 February 2021 Shine Medical Technologies, LLC - Proposed Amendment to Construction Permit for Possession of Materials PMNS20210134, Shine Medical Technologies, LLC Instrumentation and Control System Open Item Discussion2021-02-0909 February 2021 Shine Medical Technologies, LLC Instrumentation and Control System Open Item Discussion ML21019A1592021-01-27027 January 2021 Public Meeting Summary January 12 2021 PMNS20210068, Shine Instrumentation and Control Systems Open Items Discussion2021-01-15015 January 2021 Shine Instrumentation and Control Systems Open Items Discussion PMNS20201420, Shine Medical Technologies, LLC Operating License Application Environmental Technical Discussion2020-12-23023 December 2020 Shine Medical Technologies, LLC Operating License Application Environmental Technical Discussion ML20010D1692020-01-16016 January 2020 Memo to R. Elliott from J. Davis Summary of Public Scoping Meeting Conducted for the Shine Medical Technologies, LLC Operating License Application Review (Docket 50-608)w/Enclosures 1 and 2 ML17086A5662017-03-30030 March 2017 Notice of Closed Meeting with Shine Medical Technologies, Inc. to Discuss Physical Security Requirements ML16133A0942016-05-12012 May 2016 Shine Medical Technologies, Inc. Discussion on Eligible Facilities List and Construction Inspection ML14063A5882014-03-0606 March 2014 & 03/20/2014 - Notice of Forthcoming Public Meeting with Shine Medical Technologies, Inc to Discuss Topics Associated with Design Changes Related to the Proposed Shine Facility and Preliminary Safety Analysis Report ML13227A3912013-09-23023 September 2013 Summary of Public Meetings Conducted Related to the Review of the Proposed Shine Radioisotope Production Facility ML13178A3142013-07-0303 July 2013 7/17/13- Notice of Forthcoming Category 3 Public Meetings with Shine Medical Technologies, Inc. on the Environmental Scoping Process 2023-04-27
[Table view] |
Text
Advisory Committee on Reactor Safeguards SHINE OPERATING LICENSE APPLICATION SHINE Subcommittee Open/Closed October 21, 2022
- This will be a Virtual meeting with both in-person and remote capability. The bridgeline number for the meeting is 301-576-2978, passcode 554133710#. All times are Eastern.
Microsoft Teams meeting Click here to join the meeting Or call in (audio only) 1-301-576-2978,, 554 133 710#
If you would like the MSTeams link forwarded to you, please contact the Designated Federal Officer as follows: Christopher.Brown@nrc.gov .
Item Topic Presenter(s) Time 1 Opening Remarks and Objectives Professor Ronald Ballinger, ACRS 9:30 - 9:35 a.m.
2 Staff Opening Remarks Josh Borromeo, UNPL Branch Chief, NRR 9:35 - 9:45 a.m.
Section 7.4.3, Process Integrated SHINE Medical Technologies, LLC 3 Instrument Control System 9:45 - 10:15 a.m.
Section 7.4.3, Process Integrated 10:15 - 10:45 a.m.
4 NRC Staff Control System Phased Startup Operations SHINE Medical Technologies, LLC 10:45 - 11:45 a.m.
5 Supplement Phased Startup Operations, SER 11:45 - 12:15 p.m.
6 NRC Staff Appendix A 7 Public Comments Prof. Ballinger 12:15 - 12:20 p.m.
8 Closed Session, if needed SHINE Medical Technologies, LLC/NRC Staff 12:20 - 12:35 p.m.
9 Committee Discussion Prof. Ballinger 12:35 - 12:45 p.m.
10 Adjourn 12:45 p.m.
- Breaks at discretion of the Chairman ***
[NOTE: Pursuant to 5 U.S.C. 552b(c)(2) and (6), a portion of this meeting may be closed to discuss organizational and personnel matters that relate solely to internal personnel rules and practices of the ACRS, and information the release of which would constitute a clearly unwarranted invasion of personal privacy.]
NOTES:
Members of the public may observe open portions of the meeting by using the MSTeams link above or using the bridgeline number 301-576-2978 with passcode 554133710# Participants on this line will be muted except when the Chairman opens the meeting to public comment. When appropriate, members of the public and representatives of the nuclear industry may provide their views during the briefings. Contact the DFO via Email or phone for meeting slides prior to meeting.
Presentation time should not exceed 50 percent of the total time allocated for a given item. The remaining 50 percent of the time is reserved for discussion. One (1) electronic copy of the presentation materials should be provided to the ACRS in advance of the briefing.
MS Teams Meeting ID: 254 606 756 660 Passcode: aJV4qd
- Portion of meeting discussion may be CLOSED due to proprietary material
- Portion of meeting discussion may be CLOSED due to proprietary material